Kolexia
Gautier-Vargas Gabriela Néphrologie
Gautier-Vargas Gabriela
Néphrologie
Hôpital Civil
Strasbourg, France
63 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} COVID-19 Maladies du rein Maladies transmissibles Syndrome hémolytique et urémique Infections à coronavirus Syndrome de libération de cytokines Insuffisance rénale chronique Syndrome hémolytique et urémique atypique Pneumopathie virale

Collaborateurs

Voir plus
Perrin Peggy
Perrin Peggy
Hôpital Civil, Strasbourg, France
Moulin Bruno
Moulin Bruno
Hôpital Civil, Strasbourg, France
Olagne Jerome
Olagne Jerome
Hôpital Civil, Strasbourg, France
Cognard Noelle
Cognard Noelle
Hôpital Civil, Strasbourg, France

Industries

Voir plus
Otsuka
2 collaboration(s)
Dernière en 2023
AstraZeneca
1 collaboration(s)
Dernière en 2021
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Legionnaires' Disease in Solid Organ Transplant Recipients: A Decade-long Nationwide Study in France.
Chest   14 octobre 2023
Tixagevimab-cilgavimab as an Early Treatment for COVID-19 in Kidney Transplant Recipients.
Transplantation   20 juillet 2023
Prediction of Vaccine Response and Development of a Personalized Anti-SARS-CoV-2 Vaccination Strategy in Kidney Transplant Recipients: Results from a Large Single-Center Study.
Journal of personalized medicine   05 juillet 2022
Breakthrough COVID-19 cases despite prophylaxis with 150 mg of tixagevimab and 150 mg of cilgavimab in kidney transplant recipients.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons   30 juin 2022
Pre-exposure prophylaxis with 300 mg Evusheld elicits limited neutralizing activity against the Omicron variant.
Kidney international   24 mai 2022
Early Administration of Anti-SARS-CoV-2 Monoclonal Antibodies Prevents Severe COVID-19 in Kidney Transplant Patients.
Kidney international reports   26 mars 2022
Infection or a third dose of mRNA vaccine elicits neutralizing antibody responses against SARS-CoV-2 in kidney transplant recipients.
Science translational medicine   16 mars 2022
Occurrence of Donor-Specific Antibodies After COVID-19 in Kidney Transplant Recipients Is Low Despite Immunosuppression Modulation.
Kidney international reports   07 février 2022
SARS-Cov-2 Seroprevalence in a French Kidney Transplant Center Located Within a "High-risk" Zone.
Transplantation   11 octobre 2021
Strong antibody response after a first dose of a SARS-CoV-2 mRNA-based vaccine in kidney transplant recipients with a previous history of COVID-19.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons   23 juillet 2021